Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Maraninchi

Showing results (81-90 of 264) with videos related to

Pageof 27
Sort By:
Archives of Pathology & Laboratory Medicine|June 23, 2001
Vertebral metastases from pineoblastomaE Charafe-Jauffret, G Lehmann, F Fauchon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Results of fractionated TBI prior to bone marrow transplantation in standard risk leukaemia at MarseilleM Resbeut, C Altschuler, D Blaise, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term resultsF Bertucci, P Viens, J R Delpero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1989
Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemiaC Altschuler, M Resbeut, D Maraninchi, et al.
Bone Marrow Transplantation|December 1, 1994
Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectivenessC Faucher, A G le Corroller, D Blaise, et al.
Oncology|November 1, 1993
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumorsJ L Pico, A Ibrahim, L Castagna, et al.
Lancet (London, England)|June 10, 1989
Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin-2 receptorD Blaise, D Maraninchi, C Mawas, et al.
Hematology and Cell Therapy|May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technologyC Chabannon, G Novakovitch, J L Blache, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 30, 1998
[Local recurrences after conservative treatment of breast cancer: risk factors and influence on survival]D Cowen, G Houvenaeghel, J Jacquemier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Acute leukemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumorsO Hartmann, O Oberlin, J Lemerle, et al.
Pageof 27

Showing results (81-90 of 264) with videos related to

Sort By:
Pageof 27
Archives of Pathology & Laboratory Medicine|June 23, 2001
Vertebral metastases from pineoblastomaE Charafe-Jauffret, G Lehmann, F Fauchon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Results of fractionated TBI prior to bone marrow transplantation in standard risk leukaemia at MarseilleM Resbeut, C Altschuler, D Blaise, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term resultsF Bertucci, P Viens, J R Delpero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1989
Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemiaC Altschuler, M Resbeut, D Maraninchi, et al.
Bone Marrow Transplantation|December 1, 1994
Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectivenessC Faucher, A G le Corroller, D Blaise, et al.
Oncology|November 1, 1993
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumorsJ L Pico, A Ibrahim, L Castagna, et al.
Lancet (London, England)|June 10, 1989
Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin-2 receptorD Blaise, D Maraninchi, C Mawas, et al.
Hematology and Cell Therapy|May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technologyC Chabannon, G Novakovitch, J L Blache, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 30, 1998
[Local recurrences after conservative treatment of breast cancer: risk factors and influence on survival]D Cowen, G Houvenaeghel, J Jacquemier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Acute leukemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumorsO Hartmann, O Oberlin, J Lemerle, et al.
Pageof 27